Ensovibep (MP0420)

Ensovibep · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ensovibep (MP0420), covering 2023-01-18 to 2023-01-18. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19 [Phase 2, Phase 3]

See pricing